Building Your Care Team and Preparing for Success
At a Glance
To get the most out of a chronic urticaria specialist visit, patients should bring photos of their severe hives, a log of past medications, and a 7-day symptom diary. Treatment should be overseen by an allergist or dermatologist aiming for complete remission with zero hives and zero itch.
Because Chronic Spontaneous Urticaria (CSU) is an immune-mediated skin condition, it falls into the expertise of two primary types of specialists [1]:
- Allergist/Immunologists: Experts in how the immune system triggers reactions [2].
- Dermatologists: Experts in the skin’s biological response and inflammation [3].
Both are qualified to treat CSU, but you should look for a “hives specialist” or someone who explicitly mentions Chronic Urticaria in their practice focus. When calling a new office, you can ask screening questions like: “Is the doctor familiar with the EAACI step-wise guidelines for CSU?” or “Does the office routinely administer biologic injections for chronic hives?” [4][5].
Preparing for Your First Visit
The most important “test” for CSU is your medical history [6]. To get the most out of your first appointment, bring the following “Power Three” items:
- A Photo Gallery: Hives are often gone by the time you reach the doctor’s office. Take clear, well-lit photos of your hives and any swelling (angioedema) at their most severe [7].
- A Medication Log: List every antihistamine or steroid you have tried. Note the exact dose (e.g., “10mg Cetirizine once daily”) and whether it helped or caused drowsiness [7][8].
- Your UAS7 Diary: Spend the seven days leading up to your appointment recording your hive count and itch intensity [9][10]. This data is far more useful to a specialist than a one-time look at your skin [11].
What Tests to Expect (and Which to Skip)
Modern guidelines have moved away from “shotgun” testing—running dozens of blood tests to find a hidden cause [6]. In most cases, these tests are normal and only lead to more confusion [12].
- Recommended Tests: Typically limited to basic blood work like a Complete Blood Count (CBC), markers of inflammation like CRP or ESR, and thyroid tests like TSH and anti-TPO antibodies to check for the autoimmune connection [7][13][14].
- Extensive Testing: Extensive food allergy panels, screening for rare infections (like H. pylori), or total body imaging are generally not recommended unless you have specific symptoms like weight loss or severe pain [15][16].
- Biopsy: A skin biopsy is only needed if your hives are “atypical”—for example, if a single hive lasts more than 24 hours in the same spot or leaves a bruise [7][17].
Setting the Goal: Treat-to-Target
Your care team should follow a “treat-to-target” approach [18]. This means the goal isn’t just “fewer” hives; it is complete symptom remission (a UAS7 score of 0) [10].
If your doctor suggests you “just have to live with it” or only offers temporary steroid packs, it may be time to seek a second opinion from a specialist who follows the EAACI/GA²LEN international guidelines [19][18]. These guidelines provide a clear path forward when standard treatments fail, ensuring you have access to the full spectrum of modern care [20][21].
Common questions in this guide
What kind of doctor treats chronic hives?
What should I bring to my first chronic urticaria appointment?
Will my doctor run a lot of allergy tests to find the cause of my hives?
What is the treat-to-target approach for chronic urticaria?
Do I need a skin biopsy for chronic hives?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do you follow the EAACI/GA²LEN stepwise guidelines for treating chronic hives?
- 2.Is our goal 'complete control' (zero hives and zero itch), or just fewer symptoms?
- 3.Are you comfortable increasing my antihistamine dose beyond the label if the standard dose doesn't work?
- 4.If I don't respond to high-dose antihistamines, are you able to prescribe and manage biologic treatments like omalizumab in your office?
- 5.Based on my history, are there any 'atypical' features that make a skin biopsy necessary?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (21)
- 1
Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications.
Criado PR, Criado RFJ, Miot HA, et al.
Anais brasileiros de dermatologia 2025; (100(5)):501198 doi:10.1016/j.abd.2025.501198.
PMID: 40845419 - 2
Chronic Spontaneous Urticaria: A Review.
Kolkhir P, Bonnekoh H, Metz M, Maurer M
JAMA 2024; (332(17)):1464-1477 doi:10.1001/jama.2024.15568.
PMID: 39325444 - 3
Patient and physician perspectives on disease burden in chronic spontaneous urticaria: A real-world US survey.
Mosnaim G, Patil D, Kuruvilla M, et al.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2025; (134(3)):315-323.e3 doi:10.1016/j.anai.2024.11.028.
PMID: 39662669 - 4
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
Maurer M, Casale TB, Saini SS, et al.
The Journal of allergy and clinical immunology 2024; (154(1)):184-194 doi:10.1016/j.jaci.2024.01.028.
PMID: 38431226 - 5
[Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].
Costa C, Gonçalo M,
Acta medica portuguesa 2016; (29(11)):763-781 doi:10.20344/amp.8294.
PMID: 28229846 - 6
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al.
Allergy 2022; (77(3)):734-766 doi:10.1111/all.15090.
PMID: 34536239 - 7
Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements.
Giménez-Arnau A, Ferrer M, Bartra J, et al.
Allergologia et immunopathologia 2017; (45(2)):134-144 doi:10.1016/j.aller.2016.06.007.
PMID: 28029407 - 8
High-dose antihistamines for chronic spontaneous urticaria in adults.
Drug and therapeutics bulletin 2018; (56(4)):45-48 doi:10.1136/dtb.2018.4.0614.
PMID: 29650762 - 9
Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis.
Tajerian A, Pourvali A, Khoshkhui M, et al.
Archives of dermatological research.. 2024; (317(1)):131 doi:10.1007/s00403-024-03629-2.
PMID: 39673624 - 10
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.
Lima H, Gooderham M, Dutz J, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2017; (13()):38 doi:10.1186/s13223-017-0210-0.
PMID: 28852410 - 11
Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study.
Dash M, Ayub A, Vasudevan B, Sood A
Allergy and asthma proceedings 2026; (47(4)):e57-e64 doi:10.2500/aap.2026.47.260027.
PMID: 42343500 - 12
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria.
Friedman A, Kwatra SG, Yosipovitch G
Dermatology and therapy 2024; (14(6)):1371-1387 doi:10.1007/s13555-024-01173-5.
PMID: 38758422 - 13
The Relation of Autologous Serum Skin Test and Autologous Plasma Skin Test Result with Various Clinical and Laboratory Findings in Patients with Chronic Spontaneous Urticaria.
Park GH, Choi JH, Kim S, Bae Y
Annals of dermatology 2020; (32(4)):280-288 doi:10.5021/ad.2020.32.4.280.
PMID: 33911755 - 14
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria.
Kolkhir P, Altrichter S, Asero R, et al.
Allergy, asthma & immunology research 2021; (13(4)):545-559 doi:10.4168/aair.2021.13.4.545.
PMID: 34212543 - 15
Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study.
Curth HM, Dinter J, Nigemeier K, et al.
American journal of clinical dermatology 2015; (16(6)):553-8 doi:10.1007/s40257-015-0152-6.
PMID: 26334425 - 16
Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE).
Muñoz M, Salameh P, Zajac M, et al.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2026; (56(4)):411-420 doi:10.1111/cea.70215.
PMID: 41532284 - 17
Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study.
Bonnekoh H, Jelden-Thurm J, Allenova A, et al.
The journal of allergy and clinical immunology. In practice 2023; (11(9)):2900-2910.e21 doi:10.1016/j.jaip.2023.06.030.
PMID: 37364667 - 18
The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.
Maurer M, Zuberbier T, Metz M
Handbook of experimental pharmacology 2022; (268()):117-133 doi:10.1007/164_2021_506.
PMID: 34247278 - 19
Evaluating and managing chronic idiopathic urticaria in adults.
Webster L, Rider NL, Archambault ME
JAAPA : official journal of the American Academy of Physician Assistants 2018; (31(7)):22-26 doi:10.1097/01.JAA.0000534976.46365.11.
PMID: 29889715 - 20
A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.
Lapeere H, Baeck M, Stockman A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(1)):127-134 doi:10.1111/jdv.15684.
PMID: 31099916 - 21
Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta-analysis of efficacy and safety.
Alomari O, Ozceker D, Mokresh ME, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2025; (36(6)):e70132 doi:10.1111/pai.70132.
PMID: 40545961
This page provides educational information on preparing for a chronic urticaria doctor visit. It does not replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding your specific situation.
Get notified when new evidence is published on chronic idiopathic urticaria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.